Delos Clinical   Report issue

For profit Phase 3
Founded: Seville Spain (2011)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2016
NCT02942498
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

vitamin c (1 trial)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Child Behavior Disorders (Phase 3)

Fragile X Syndrome (Phase 3)

Mental Disorders (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2